Skip to content

Research on Yuanheng Solid Beverage Relieving Mitochondrial Aging Dysfunction

Research on Yuanheng Solid Beverage Relieving Mitochondrial Aging Dysfunction

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047734
Enrollment
Unknown
Registered
2021-06-25
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitochondrial dysfunction during aging

Interventions

Experimental group:Yuanheng Solid Drink, 2 bags per use, once daily, dissolved with warm water, treat for 16 weeks (equal to 112 days)

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 45 to 60 years, healthy pre-senile men; 2. 18.5<= BMI<30; 3. Able to act independently; 4. Non-heavy manual workers; 5. There is no large amount of exercise during the test; 6. No longer participate in clinical trials of any other research center during the trial; 7. Voluntarily sign the informed consent; 8. After the primary screening of the PPSHAS scale, the grades iii and iv of aging are selected. If the number of cases of grade IV can meet the target of 40 cases, the grade IV is preferred.

Exclusion criteria

Exclusion criteria: 1. There is a malabsorption syndrome that may affect the absorption of the test substance; 2. Those who work night shifts or alternate between day shifts and night shifts; 3. Allergic to herbal supplements; 4. Those who have used anti-aging products within 1 month before the start of the trial; 5. Dyslexia; 6. Currently have the habit of smoking; 7. Drinking alcohol more than 14 times a week; 8. Any situation that the researcher considers inappropriate to participate in this research.

Design outcomes

Primary

MeasureTime frame
Morphological observation of mitochondria in peripheral blood immunocytes;Copy number of mtDNA in peripheral blood immunocytes;Mitochondrial membrane potential of peripheral blood mononuclear cells;coenzyme i level in serum;Sirt1 level in serum;8-oxodG level in serum;

Secondary

MeasureTime frame
Decreasing rate of Malondialdehyde level in serum;Upgrade rate of Superoxide Dismutase in serum;advanced glycation end products level in serum;

Countries

China

Contacts

Public ContactZheng Yuxin

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

sg_zyx1728@126.com+86 13816256086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026